Blackboxstocks (BLBX) Appoints Keller Reid to Board of Directors
Get Alerts BLBX Hot Sheet
Join SI Premium – FREE
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), a financial technology and social media hybrid platform offering real-time proprietary analytics for stock and options traders of all levels, announced today that it has appointed Mr. Keller Reid to its board of directors, effective immediately. Mr. Reid replaces Andrew Malloy, who resigned.
Mr. Reid has extensive experience in the strategy and technology of trading systems. He has been at Ackerman Capital Management, a Dallas-based family office, for fourteen years and is currently responsible for trading and execution and oversees the technological infrastructure of the firm. Previously, Mr. Reid served as Vice President, Head of Execution Sales and Strategy at Apex Clearing. He joined Apex via their acquisition of Penson Clearing, where his positions included Head of Execution Services and Trading, and Chief Operating Officer of Penson Execution Services. While at Penson, Mr. Reid developed an electronic routing algorithm that was granted a patent by the United States Patent and Trademark Office, (U.S. 8015099). Mr. Reid also served as a Director of the Dallas Security Traders Association for fourteen years and was a long-standing member of the Security Traders Association Retail Roundtable and SIFMA Listed Options Trading Committee.
Gust Kepler, Chief Executive Officer of Blackboxstocks, commented, “We are extremely pleased to welcome Keller Reid as a member of our board. We believe that Keller’s vast industry knowledge and long standing relationships with leading financial institutions will benefit Blackbox as we launch an initiative to sell our proprietary technology on an enterprise level and expand our addressable market to include a B2B model.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citius Pharmaceuticals (CTXR) Advances Efforts to Spin Off I/ONTAK into Standalone Company
- Cadrenal Therapeutics (CVKD) Provides FY22 Corporate Update
- Twilio (TWLO) Appoints Charlie Bell to its Board
Create E-mail Alert Related Categories
Board Changes, Corporate NewsRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!